Real-time enrollment status for this glioblastoma clinical trial
Current Status
Recruiting
Checked: September 7, 2026 at 6:56 PM UTC
| NCT Number | NCT04590664 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Emory University |
| Last Updated on CT.gov | February 25, 2025 (Feb 25, 2025) |
As of September 7, 2026: Clinical trial NCT04590664 is currently recruiting participants. This phase1 study for glioblastoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Emory University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04590664 is actively recruiting participants as of September 7, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04590664 was last updated Feb 25, 2025 (February 25, 2025). HelloStudys verifies this status automatically.